N-Desmethyltamoxifen hydrochloride
Cat. No.：YN310199
CAS No. ：15917-65-4
| 产品名称: | N-Desmethyltamoxifen hydrochloride |
| CAS No.: | 15917-65-4 |
| Chemical Name: | (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N-methylethanamine Hydrochloride; |
| Synonyms: | Ethanamine,2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N-methyl-, hydrochloride (9CI);N-DESMETHYL TAMOXIFEN HCL;N-Desmethyl Tamoxifen Hydrochloride;(Z)-2-(p-(1,2-Diphenyl-1-butenyl)phenoxy)-N-methylethylamine ICI 55,548;(Z)-2-[4-(1,2-Diphenyl-1-butenyl)phe |
| 分子量: | 393.95 |
| 分子式: | C₂₅H₂₈ClNO |
| SMILES: | CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCNC)C=C2)\C3=CC=CC=C3.[H]Cl |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | N-Desmethyltamoxifen hydrochloride 是 Tamoxifen 在人体内的主要代谢产物。N-Desmethyltamoxifen，较弱的抗雌激素，是一种比 Tamoxifen 强十倍的蛋白激酶 C(PKC)抑制剂。N-Desmethyltamoxifen hydrochloride 也是人体 AML 细胞神经酰胺代谢的有效调节因子，限制神经酰胺糖基化、水解和鞘氨醇磷酸化。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Fabian, C., et al.: Biopharm. Drug Dispos., 2, 381 (1981), Jordan, V., et al.: Breast Cancer Res. Treat., 15, 125 (1990), Mandlekar, S., et al.: Cancer Res., 60, 6601 (2000), Lim, Y., et al.: Cancer Chemother. Pharmacol., 55, 471 (2005), Rouanet, P., et al.: J. Clin. Oncol., 2005, 23, 2980 (2005)
